Dr. Fransiska Kurniawan, S.Farm., M.Si.

Personal Information

1	Name	Dr. Fransiska Kurniawan, S.Farm., M.Si.
2	Gender	Female
4	E-mail address	siska@fa.itb.ac.id; fransiskakurniawan@yahoo.com
6	Institution	Bandung Institute of Technology
7	Office address	Jl. Ganesha 10, Bandung
8	Office phone/fax number	+6222-2504852

Education Background

	Bachelor	Master	Doctoral
Institution Name	ITB	ITB	ITB
Field of Study	Pharmacy	Pharmacy	Pharmacy
Graduated year	2013	2015	2018
Title of thesis/dissertation	Preliminary study of clorination reaction of sucrose as initiation of sucralose (4,1’,6’-Triklorogalaktosukrosa)	Design and in silico study of diazolylporphyrin derivatives as a candidate of radiopharmaceutical ligand kit for melanoma cancer	In silico study, synthesis, and cytotoxicity test of porphyrin derivatives as candidate of anticancer agents and radiopharmaceutical ligand kit
Supervisor(s)	Dr.rer.nat Rahmana Emran Kartasasmita; Prof. Dr. Daryono Hadi Tjahjono, M.Sc.	Prof. Dr. Daryono Hadi Tjahjono, M.Sc.; Dr.rer.nat Rahmana Emran Kartasasmita	Prof. Dr. Daryono Hadi Tjahjono, M.Sc.; Dr.rer.nat Rahmana Emran Kartasasmita; Dr. Abdul Muthalib

Research Experience in the Last 5 Years

No.	Year	Title	Funding
No.	Year	Title	Source*	Total in IDR (million)
1	2020	Study of antivirus molecules for SARS-CoV-2 by in silico method	RISTEKBRIN	195
2.	2020	Porphyrin derivatives as radiopharmaceutical kit for cancer diagnostic	Kemenristek/BRIN	456,5
3.	2020	In silico study and synthesis orientation of caffeine derivatives as anticancer candidate	P3MI ITB	100
	2019	Development of Food Additives (BTP) Safety Evaluation Methods Based on Computing Methods (In Silico) As a Supporting System in Policy Implementation	LPDP	327,6
	2019	Safety Study of Sildenafil and Its Derivatives Using the In Silico Method	P3MI ITB	100
4.	2019	Porphyrin derivatives as radiopharmaceutical kit for cancer diagnostic	Kemenritek-dikti	237,6
5.	2018	In vivo study of porphyrin derivatives as anticancer candidate	Riset ITB	250
	2017	Development of mefenamic acid synthesis as an effort to encourage national independence in the provision of Active Pharmaceutical Ingredients (API)	Kemenkes RI	238,5
6.	2017	Development of porphyrin derivatives as radiopharmaceutical ligands, photosensitizer, and anticancer	Kemenritek-dikti	416,5
7.	2016	Development of porphyrin derivatives as radiopharmaceutical ligands, photosensitizer, and anticancer	Kemenritek-dikti	450
	2016	Collaborative Research at Department of Applied Chemistry, Keio University, Japan (Program Sandwich-Like)	DIKTI	95
8.	2016	Synthesis of porphyrin derivatives and labeling with ^99mTc as radiopharmaceutical kit ligand	Riset KK ITB	150
9.	2015	Development of porphyrin derivatives as radiopharmaceutical ligands, photosensitizer, and anticancer	Kemenritek-dikti	381
10.	2015	Study of reactivity, structure, and complex electronic properties of porphyrin derivatives with transition metal using density functional theory (DFT) method	Riset KK ITB	150

Scientific Article Publication in The Last 5 Years

No.	Title	Journal	Vol./ No./Year
1	Determination of anthraquinone in some Indonesian black tea and its predicted risk characterization	ACS Omega	5/32/2020
2	Study of Molecular Docking and Molecular Dynamic of Flavonol Compounds as a B-Cell Lymphoma-2 (BCL-2) Receptor Inhibitor in Small Lung Cancer	International Journal of Advanced Research	8/03/2020
3	Pharmacophore and Molecular Docking-Based Virtual Screening of B-Cell Lymphoma 2 (BCL 2) Inhibitor from Zinc Natural Database as Anti-Small Cell Lung Cancer	Journal of Drug Delivery and Therapeutics	10/2/2020
4	Computational Study of Imidazolylporphyrin Derivatives as a Radiopharmaceutical Ligand for Melanoma	Current Computer-Aided Drug Design	14/2018
5	In Silico Study, Synthesis, and Cytotoxicity Activities of Porphyrin Derivatives	Pharmaceuticals	11/8/2018

Seminar/Conference Speaker (Oral Presentation) in The Last 5 Years

No	Conference Name	Title	Time and Place
1	1^st AASP Young Scientist Conference 2020	Preliminary Study of Reaction Mechanism of Porphyrin Synthesis	11-13 Desember 2020, Yogyakarta
2	5^th International Conference on Computation for Science and Technology (ICCST)	Investigation of the Mechanism of Diazolylporphyrin as Novel Breast Cancer Radiopharmaceutical Ligand	23-26 September 2018, Antalya, Turkey
3	2^nd Bandung International Conference on Medicinal Chemistry (ICMC 2017)	In Silico Study, Synthesis, and Cytotoxicity Test of Porphyrin Derivatives as Candidate of Anticervical Cancer Agents	5-6 October 2017, Bandung, Indonesia
4	4^th International Conference on Computation for Science and Technology (ICCST)	Computational Study of the Reaction Mechanism of Phenyl-Dipyrromethane Synthesis	3-4 November 2016, Langkawi, Malaysia

Intellectual Property Rights in The Last 10 Years

No.	Title	Year	Type	No.
1	Senyawa Turunan Porfirin Sebagai Antikanker dan Ligan Radiofarmaka Serta Metode Sintesisnya	2018	Paten	P00201809524

Awards in The Last 10 Years

No.	Title	Awarded by	Year
1.	First Runner-Up Oral Presenter in The 2^nd International Conference on Medicinal Chemistry	Committee of BICMC 2017	2017
2.	Beasiswa PMDSU	DIKTI	2013-2017
3.	Scholarship Sandwich-like Program, DIKTI, Keio University, Jepang, dengan supervisor Prof. Naoki Yoshioka	DIKTI	2016
4.	Scholarship Sandwich-like Program, DIKTI, Keio University, Jepang, dengan supervisor Prof. Naoki Yoshioka	DIKTI	2015